A2 Biotherapeutics

Innovating New Treatments for Solid Tumors

Agoura Hills, United States · Founded 2018 · $208.5M raised

Founded
2018
Business Model
B2B
Website
a2bio.com
Total Funding
$208.5M
Last Round
$80.0M Series CJan 2025
Rounds
3

About

A2 Biotherapeutics is a clinical-stage cell therapy company developing first-in-class logic-gated CAR T-cell therapies for solid tumors using its proprietary Tmod technology platform. Founded in 2018 by Alexander Kamb, Michael Gallo, and Paul Kang, the company is headquartered in Agoura Hills, California, and is advancing multiple T-cell programs targeting cancers with unmet need.

Summary

A2 Biotherapeutics is a Biotech company based in Agoura Hills, United States, founded in 2018. It has raised $208.5M in total across 3 rounds, most recently a $80.0M Series C round in Jan 2025. Investors include Nextech Invest, Vida Ventures and Section 32.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CJan 2025
$80.0M

Sign up to see all 3 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

A2 Biotherapeutics on Indexed.vc
<a href="https://indexed.vc/companies/a2-biotherapeutics"><img src="https://indexed.vc/api/badge/company/a2-biotherapeutics" alt="A2 Biotherapeutics on Indexed.vc" width="260" height="76" /></a>